Stonepine Capital Management, LLC Nektar Therapeutics Transaction History
Stonepine Capital Management, LLC
- $126 Billion
- Q1 2024
A detailed history of Stonepine Capital Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 3,480,409 shares of NKTR stock, worth $4.32 Million. This represents 2.58% of its overall portfolio holdings.
Number of Shares
3,480,409Holding current value
$4.32 Million% of portfolio
2.58%Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
128Shares Held
111MCall Options Held
150KPut Options Held
4K-
Deep Track Capital, LP Greenwich, CT18.4MShares$22.8 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$14.9 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA7.57MShares$9.39 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA6.97MShares$8.64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.88MShares$7.29 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $232M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...